Big Pharma Jobs Slammed, But Biotech Hiring Helps

With all the restructuring and strategic scrambling over the past several years, one could be forgiven for thinking that the pharmaceutical industry has drastically reduced its headcount. After all, government payers have become tougher to convince when pitching the merits of a new drug and, of course, the patent cliff has sapped revenue from brand-name drugmakers as low-cost generic rivals have arrived.